Status:
TERMINATED
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
HealthPartners Institute
Conditions:
Atopic Dermatitis
Eczema
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
To evaluate the efficacy of water bath, water + bleach, and water + vinegar (acetic acid) in the treatment of atopic dermatitis (eczema)
Detailed Description
To perform a randomized controlled study to evaluate the efficacy of adding dilute acetic acid to the bath twice weekly on the Eczema Area and Severity Index (EASI) score as compared to adding dilute ...
Eligibility Criteria
Inclusion
- Currently reside in the USA
- Ability to comply with follow up visits at 2-4 months and at 6 months
- Come to the last follow-up at 6 months in the clinic
- At least 5% Body Surface Area (BSA) affected with AD
Exclusion
- Unclear diagnosis of atopic dermatitis
- Inability to comply with additive baths
- Inability to comply with follow-up visits
- Lack of residence in the United States
Key Trial Info
Start Date :
February 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03775590
Start Date
February 21 2019
End Date
September 15 2019
Last Update
May 12 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
2
HealthPartners
Saint Paul, Minnesota, United States, 55130